Fletcher Payne
CIK 1650476 · View on SEC EDGAR ↗
First SEC filing: Jan. 16, 2018 · Latest: Jan. 16, 2018
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 17, 2015 | GYRE | P | 10,000 | $2.00 | $20,000 | 25,032 Indirect | +66.52% | Acquired | -98.4% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 4, 2019 | GYRE | Stock Option (Right to Buy) | Common Stock (1,503) | $4.63 | July 11, 2027 | 1,503 | Disposed |
| Jan. 24, 2019 | GYRE | Stock Option (Right to Buy) | Common Stock (38,000) | $7.97 | Jan. 24, 2029 | 38,000 | Acquired |
| July 30, 2018 | GYRE | Stock Option (Right to Buy) | Common Stock (25,000) | $9.68 | July 30, 2028 | 25,000 | Acquired |
| March 26, 2018 | GYRE | Stock Option (Right to Buy) | Common Stock (59) | $4.63 | July 11, 2027 | 59 | Disposed |
| Jan. 12, 2018 | GYRE | Stock Option (Right to Buy) | Common Stock (26,000) | $15.13 | Jan. 12, 2028 | 26,000 | Acquired |
| July 11, 2017 | GYRE | Stock Option (Right to Buy) | Common Stock (75,000) | $4.63 | July 11, 2027 | 75,000 | Acquired |
| Oct. 22, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock (28,572) | $4.40 | Oct. 22, 2025 | 28,572 | Acquired |
| Oct. 22, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock (71,428) | $4.40 | Oct. 22, 2025 | 71,428 | Acquired |
| Oct. 22, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock (28,572) | $4.40 | Oct. 22, 2025 | 28,572 | Acquired |
| Aug. 20, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock (14,325) | $6.03 | May 8, 2025 | 14,325 | Acquired |
| Aug. 20, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock (2,440) | $7.60 | Jan. 22, 2025 | 2,440 | Acquired |
| Aug. 20, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock (7,320) | $7.60 | Jan. 22, 2025 | 7,320 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $252,800 | — | — | — | — | — | $2,047 | $471,208 |
| 2018 | $345,301 | $120,855 | — | — | — | — | $2,092 | $969,476 |
| 2017 | $335,244 | $152,536 | — | — | — | — | $2,092 | $779,223 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.